Vera Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VERA | ABCL | 1873.HK | VIR | BHVN | DNTH | |
|---|---|---|---|---|---|---|
| Market cap | 2.30B | 3.98B | 2.80B | 1.99B | 2.30B | 4.80B |
| P/E (TTM) | — | — | 16.9 | — | — | — |
| Forward P/E | -7.5 | -16.1 | 6.2 | -4.8 | -8.2 | -18.6 |
| Price/book | 5.6 | 4.2 | 0.6 | 2.1 | -23.4 | 7.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +27.43% | +171.08% | −43.17% | +129.88% | +78.66% | +135.55% |
| Today | +4.10% | +0.82% | +5.04% | +4.90% | −2.37% | +3.76% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VERA news ›Vera Health Raises $28.5 Million Series A, Bringing Total Funding To $32 Million
Vera Health has raised a $28.5 million Series A led by Threshold Ventures, bringing total funding for its clinical evidence platform to $32 million as adoption expands among healthcare professionals around the world. Mantis VC and SV Angel…
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
BRISBANE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that it will host two upcoming investor webcasts to discuss ORIGIN 3 final efficacy…
Wedbush Sticks to Their Hold Rating for Vera Therapeutics (VERA)
Wedbush analyst Laura Chico maintained a Hold rating on Vera Therapeutics today and set a price target of $34.00. Chico covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Vera Therapeutics, and Biogen.…
Guggenheim Reaffirms Their Buy Rating on Vera Therapeutics (VERA)
In a report released today, Vamil Divan from Guggenheim reiterated a Buy rating on Vera Therapeutics, with a price target of $76.00. Divan covers the Healthcare sector, focusing on stocks such as Travere Therapeutics, Jade Biosciences, and…
Vera Therapeutics Announces Chief Regulatory Officer Changes, Effective August 3, 2026
Vera Therapeutics, Inc. announced a planned transition of the Chief Regulatory Officer position. William Turner, current Chief Regulatory Officer of Vera Therapeutics, is planning to retire and... announced a planned transition of the…
Transcript : Vera Therapeutics, Inc. - Special Call
Presentation Operator MessageOperator Good day, everyone. Welcome to the Vera Therapeutics October 22 Investor Webcast. [Operator Instructions] This call is being recorded. If you have any Transcript : Vera Therapeutics, Inc. - Special…
Vera Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Vera Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time VERA price, Nasdaq stock exchange Relative Strength Chart Vera Therapeutics, Inc. Biotechnology & Medical Research All financial news…
Vera Therapeutics, Inc. (VERA) Discusses Final Efficacy Results of ORIGIN Phase III Trial of Atacicept in IgA Nephropathy Transcript
Vera Therapeutics, Inc. (VERA) Discusses Final Efficacy Results of ORIGIN Phase III Trial of Atacicept in IgA Nephropathy October 22, 2026 4:30 PM EDT Marshall Fordyce - Founder, President, CEO & DirectorMatt Skelton - Chief Commercial…
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
Callan JMB to Break Ground on IV Bag Manufacturing Facility Fully Funded by Non-Dilutive and Non-Interest-Bearing Third-Party Partnership Gix Internet: Quantum X Labs Achieved Key Milestones with NVIDIA CUDA-Q Decoder and IBM Quantum…
Leerink Partners Begins Coverage on Vera Therapeutics (NASDAQ:VERA)
Posted by Defense World Staff on Oct 12th, 2026 Leerink Partners began coverage on shares of Vera Therapeutics (NASDAQ:VERA – Get Free Report) in a research note issued to investors on Monday, Benzinga reports. The brokerage set a “market…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com7
- markets.businessinsider.com5
- defenseworld.net1
- pulse2.com1
- seekingalpha.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.